fulvestrant has been researched along with Genome Instability in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabil, A; Kortenkamp, A; Silva, E | 1 |
| Akli, S; Chang, S; Keyomarsi, K; Multani, AS; Pathak, S; Tucker, SL; Wingate, HF; Zhang, N; Zheng, PJ | 1 |
2 other study(ies) available for fulvestrant and Genome Instability
| Article | Year |
|---|---|
Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals.
Topics: Benzhydryl Compounds; Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogens; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Fulvestrant; Genomic Instability; Humans; Kinetochores; Micronuclei, Chromosome-Defective; Phenols; raf Kinases; Receptors, Estrogen; Signal Transduction; src-Family Kinases; Tamoxifen | 2008 |
Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Breast Neoplasms; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; G1 Phase; Genomic Instability; Humans; Middle Aged; Molecular Weight; Polyploidy; Protein Isoforms; Transfection; Tumor Suppressor Proteins | 2004 |